Spurious medicines prevalent in India

Recently Spurious Drugs have been seized in Zirakpur and In Tripura. In Tripura, the Local court has sent 9 persons accused of manufacturing adulterated drugs to the 5 days police custody for further investigation. Names are disclosed by West Tripura Police as 39 years old Biswajit Chakraborty, 32 years old Subir Majumder, 18 years old Tamal Das, 40 years old Subra Deb, 35 years old Bishnu Paul, 28 years old Chentu Sarkar, 30 years old Tapash Dhar, 40 years old Dilip Das and 19 years old Sagar Debbarma.

West Tripura Police SP Ajit Pratap Singh told to the media that they raided the house on the basis of the received information and seized raw material that will be used to prepare banned drug Phensedyl in a large quantity of, comprising contraband chemicals. The seized material involved 280 bottles of intake Phensedyl, 6,175 empty corks, 120 empty bottles, 15 kg sugar, 7 kg saccharine, 3 kg of baking soda and 50 liters of raw liquid Phensedyl. These all things were bought with the purpose to manufacture adulterated Phensedyl.
Then after the adulterated drug was planned to supply in the different local markets besides, smuggling to the neighboring country.

Another case reported in the Zirakpur Punjab, where The Punjab Food and Drug Administration seized fake drugs of worth Rs 7.55 lakh during a surprise check on various manufacturing units in Zirakpur.

Acting on informational Tip, Team from Food and drug regulator deputed under the directions of KS Pannu, Commissioner, Food and Drugs Administration, Punjab, conducted surprise checks at Exotic Healthcare, San Houston, NB Healthcare, Zoic Healthcare and United Laboratories.
The teams drew 16 samples of various drug formulations manufactured by the local food supplements and manufacturing units for analysis. The teams also checked records of the firms.

KS Pannu said that his team planned to run focus campaign to weed out fake and low-quality drugs from the market. He also said that some drug manufacturers and traders involved in this illegal activity for the purpose of extorting money. During their raid, they also found that the food supplement and drug manufacturing companies engaged in the illegal manufacture of some drug formulations.

A fresh drug alert has been issued by the Central Drugs Standard Control Organization (CDSCO) in J&K over the recall of low quality and fake drugs from the open market and hospitals.

CDSCO also ordered DFCO(Drug and Food Control Organisation) to increase the raid intensity of the market and make regular raids on suspected distributors of “spurious drugs”.J&K was topmost place in the previous records for the substandard drugs many times. J&K Drug board issued alert after the news of the spurious drugs manufactured by the top companies were found in Rajasthan.

CDSCO official told the media that the same medicines manufactured by top companies that also supply drugs to J&K were found to be counterfeit in Rajasthan.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices